CVS splits retail and insurance units as stock lags

CVS is executing a long-planned split, separating its retail pharmacy network, walk-in clinics, and technology into a new company, while the core entity will retain its insurance business, Aetna, and pharmacy benefit management operations. The stock price declined following the announcement, a move interpreted by market observers as an admission that the integrated healthcare model has not succeeded over the past decade. CVS trades at a P/E of 10, a level it has maintained for ten years without structural profit growth, resulting in returns limited to dividends.

The split aims to separate the regulatorily sensitive insurance and PBM business from the more comfortable retail segment. Walgreens, a former competitor, has gone private, leaving CVS as the primary public player in this space. The strategic retreat reflects the challenges of combining retail and insurance operations, with the new structure intended to allow each business to operate more efficiently. Investors remain cautious, noting that the structural change may not provide the catalyst needed for a re-rating of the stock, given the persistent low valuation and lack of significant growth drivers in the retail segment.